Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 582

1.

Implantable cardioverter-defibrillators for secondary prevention: is it worth it in the elderly?

Traub D, Ganz L.

Am J Geriatr Cardiol. 2006 Mar-Apr;15(2):93-9; quiz 100-1. Review.

PMID:
16525222
2.

Role of the implantable defibrillator among elderly patients with a history of life-threatening ventricular arrhythmias.

Healey JS, Hallstrom AP, Kuck KH, Nair G, Schron EP, Roberts RS, Morillo CA, Connolly SJ.

Eur Heart J. 2007 Jul;28(14):1746-9. Epub 2007 Feb 5.

PMID:
17283003
3.

Implantable cardioverter-defibrillators for primary prevention: how do the data pertain to the aged?

Daubert JP, Sesselberg HW, Huang DT.

Am J Geriatr Cardiol. 2006 Mar-Apr;15(2):88-92. Review.

PMID:
16525221
4.

Prevention of sudden cardiac death.

Prystowsky EN.

Clin Cardiol. 2005 Nov;28(11 Suppl 1):I12-8. Review.

5.

Use of traditional and biventricular implantable cardiac devices for primary and secondary prevention of sudden death.

Klein MH, Gold MR.

Cardiol Clin. 2008 Aug;26(3):419-31, vi-vii. doi: 10.1016/j.ccl.2008.03.006. Review.

PMID:
18538188
6.

Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.

Ghanbari H, Dalloul G, Hasan R, Daccarett M, Saba S, David S, Machado C.

Arch Intern Med. 2009 Sep 14;169(16):1500-6. doi: 10.1001/archinternmed.2009.255.

PMID:
19752408
7.

Implantable cardioverter-defibrillators should be used routinely in the elderly.

Buxton AE.

Am J Geriatr Cardiol. 2006 Nov-Dec;15(6):361-4; quiz 365-6. Review.

PMID:
17086029
9.

Implantable cardioverter defibrillators in primary and secondary prevention: a systematic review of randomized, controlled trials.

Ezekowitz JA, Armstrong PW, McAlister FA.

Ann Intern Med. 2003 Mar 18;138(6):445-52. Review.

PMID:
12639076
10.

The implantable cardioverter-defibrillator: does everybody need one?

Raj SR, Sheldon RS.

Prog Cardiovasc Dis. 2001 Nov-Dec;44(3):169-94. Review.

PMID:
11727276
11.
12.

Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators.

Bollmann A, Husser D, Cannom DS.

Am J Cardiovasc Drugs. 2005;5(6):371-8. Review.

PMID:
16259525
13.

The Italian Implantable Cardioverter-Defibrillator Registry. A survey of the national activity during the years 2001-2003.

Proclemer A, Ghidina M, Cicuttini G, Gregori D, Fioretti PM.

Ital Heart J. 2005 Mar;6(3):272-80.

PMID:
15875520
14.

Unresolved issues in implantable cardioverter-defibrillator therapy.

Mason PK, DiMarco JP.

Cardiol Clin. 2008 Aug;26(3):433-9, vii. doi: 10.1016/j.ccl.2008.03.008. Review.

PMID:
18538189
15.

Effect of concomitant antiarrhythmic therapy on survival in patients with implantable cardioverter defibrillators.

Ho AT, Pai SM, Timothy P, Pai RG.

Pacing Clin Electrophysiol. 2005 Jul;28(7):647-53.

PMID:
16008799
16.

Implantable cardioverter defibrillator utilization based on discharge diagnoses from Medicare and managed care patients.

Ruskin JN, Camm AJ, Zipes DP, Hallstrom AP, McGrory-Usset ME.

J Cardiovasc Electrophysiol. 2002 Jan;13(1):38-43.

PMID:
11843481
17.

Sudden cardiac death and implantable cardioverter-defibrillators.

Turakhia MP.

Am Fam Physician. 2010 Dec 1;82(11):1357-66. Review.

19.
20.

Impact of the main implantable cardioverter-defibrillator trials in clinical practice: data from the Italian ICD Registry for the years 2005-07.

Proclemer A, Ghidina M, Gregori D, Facchin D, Rebellato L, Fioretti P, Brignole M.

Europace. 2009 Apr;11(4):465-75. doi: 10.1093/europace/eun370. Epub 2009 Jan 9.

PMID:
19136490

Supplemental Content

Support Center